Dasatinib inhibits both osteoclast activation and prostate cancer PC-3 cell-induced osteoclast formation

Title
Dasatinib inhibits both osteoclast activation and prostate cancer PC-3 cell-induced osteoclast formation
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 8, Issue 22, Pages 2153-2159
Publisher
Informa UK Limited
Online
2011-02-04
DOI
10.4161/cbt.8.22.9770

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started